SUMMARY The histological features of 40 spleens surgically removed from maintenance haemodialysis patients are reported. Twenty-four of the 40 (60%) showed massive iron loading and a significant direct correlation was found between iron loading and the amount of intravenous iron dextran administered. Since parenteral iron dextran appears to be a major factor in causing iron overload in haemodialysis patients its use as a method of iron replacement in these patients would appear inappropriate.
The spleens of patients maintained by regular haemodialysis are usually enlarged' and may show variable degrees of siderosis. 2 Previous histological studies have also demonstrated lymphoid hyperplasia3 and foreign inclusions4 thought to be fragments of silastic from the pump insert of the haemodialysis circuit. There has been no consensus as to the cause of the splenic enlargement and which, if any, of the above histological features contribute to it. Maintenance haemodialysis is an irondepleting process56 for which oral or intravenous iron replacement is required. The appropriateness of intravenous iron dextran for this purpose has recently been questioned because many haemodialysis patients have been found to have siderosis of the liver and spleen accompanied by very high serum ferritin concentrations.7 However, there is still controversy about the relative roles of intravenous iron dextran, oral iron supplements and blood transfusions in the causation of this iron overload.8 We have studied the histology of 40 spleens removed from regular haemodialysis patients in conjunction with their clinical histories to try to answer some of these questions.
Patients and methods
The patients had been maintained on regular haemodialysis (ranging from three months to 11 yr) performed three times per week for 5 to 7h each session. Patients used either a one square metre Kiil cells in this location were frequently clustered into groups (Fig. 4) . The red pulp appeared prominent together with congestion of the splenic sinusoids. In most respects the white pulp appeared normal but germinal centre formation was not observed. No foreign-body giant cells or macrophages with inclusion bodies were seen. No other histopathological abnormality was found including the spleen of 625 g. Absolute reticulocyte counts were not raised in 22 patients who were studied and the serum bilirubin, haemopexin and haptoglobin concentrations were within normal limits. No methaemalbumin could be detected in patients' sera.
Serum ferritin concentrations measured in 17 patients showed a good correlation with the qualitative grading of splenic iron stores. Six patients with normal (1 +) splenic iron had a mean serum ferritin 
Discussion
Our study has shown that spleens removed from our regular haemodialysis patients were siderotic. The group as a whole had received very small amounts of blood and there was no correlation between the presence of gross iron loading and volume of blood transfused. However, there was a very strong corre- lation between iron load and amount of intravenous iron administered. The avoidance of iron loading depends on the regulation of iron absorption, since there is no physiological route for the excretion of excess amounts.9 The normal regulatory mechanisms con- Murray, Slater, Parsons, Fox, Smith, Platts trolling iron absorption are usually maintained in patients on regular haemodialysis,'0 but are bypassed when iron is administered parenterally as iron dextran or transfused blood. Only one of our eight patients who had received oral but no intravenous iron showed moderately increased iron stores in the spleen. Iron overload after oral iron therapy is extremely uncommon," but we have observed one uraemic patient who had taken oral iron for many years who presented before any dialysis with a serum ferritin of 7000 ,ug/1. In some cases, therefore, it would appear that abnormal absorption of oral iron may account for iron loading. In general, however, oral therapy is safer than parenteral replacement with less likelihood of iron overload. One study demonstrated that oral ferrous sulphate was superior to iron dextran in terms of improvement in the haematocrit. '2 Excess iron stores are undoubtedly utilised to some extent since haemodialysis patients with high ferritin concentrations after intravenous iron maintained their haemoglobin whilst the serum ferritin fell.'3 Our experience is that raised serum ferritin concentrations do not show a pronounced fall when intravenous iron is discontinued, the ferritin having been demonstrated to be a reliable determinant of iron stores in haemodialysis patients.'4's The patients in this study maintained or improved their haemoglobin after splenectomy but this would have been expected as many patients went on to receive a successful renal transplant. Utilisation of excess iron stores may well be transitory and there is a tendency for reticuloendothelial iron dextran stores to become progressively unavailable with time. ' 6 This phenomenon appears to be similar to the block in iron release seen in individuals with chronic inflammatory states. Further evidence for the impaired release of iron for effective haemopoiesis has been provided by Ali et al,7 who described absent marrow iron stores in some haemodialysis patients who nevertheless had marked hepatosplenic siderosis. Siderosis has been demonstrated previously in The prominence of the red pulp in our cases is consistent with the presence of red pulp hyperplasia as previously described in haemodialysis patients. However, we have not observed the lymphoid hyperplasia described by Neiman.3 This may be because our patients had not suffered from hepatitis since Neiman ascribed splenic enlargement in haemodialysis to chronic infection, particularly hepatitis. There was no significant difference in the weights of the spleens of the siderotic and nonsiderotic groups although there was a trend for spleen weight to increase with iron loading. This study, therefore, does not support iron deposition, lymphoid hypertrophy or the presence of inorganic foreign bodies in the spleens of haemodialysis patients as causes of the splenomegaly as suggested by other workers. It would appear possible that the splenomegaly was due to red pulp hyperplasia.
The spleens in this study were a selected group removed because of clinical hypersplenism. It is, therefore, not surprising that they were enlarged.
However, Platts et al (personal communication) have shown by radioisotope imaging of the spleens of a large population of haemodialysis patients that splenomegaly is a general finding and not seen in other uraemic patients who are either undialysed or treated by peritoneal dialysis. Hypersplenism itself can result in splenic haemosiderin deposition. However, it is not a constant finding and rarely appears heavy. In addition, the iron tends to be restricted to the sinusoidal lining cells.2324 Consequently we consider it unlikely that hypersplenism was the cause of the consistent and heavy iron overload seen in these patients.
On the basis of these findings we believe that parenteral iron dextran is a major factor causing iron overload in haemodialysis patients and is, therefore, an inappropriate form of therapy for this group.
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